Tiagabine Hydrochloride
10 NDCs across 3 manufacturers|10 Generic,0 Brand
Tiagabine Hydrochloride is used to treat bipolar disorder and partial epilepsies, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 30, 1997, and the first generic was approved Nov 4, 2011. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient.
Tiagabine Hydrochloride is available as 10 NDCs from 3 manufacturers (10 generic, 0 brand), with NADAC prices from $1.92 to $6.62 per EA — the most expensive product costs about 3.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
10G / 0B
Manufacturers
3
competing in market
Price Spread
$1.92 – $6.62
per EA
7d Activity
avg +6.5% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anti-epileptic Agent class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing TIAGABINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TIAGABINE HCL 12 MG TABLET | $6.6190 per EA | -0.31% |
TIAGABINE HCL 12 MG TABLET | $6.6190 per EA | -0.31% |
TIAGABINE HCL 16 MG TABLET | $6.0268 per EA | — |
TIAGABINE HCL 16 MG TABLET | $6.0268 per EA | — |
TIAGABINE HCL 2 MG TABLET | $2.6218 per EA | +8.68% |
TIAGABINE HCL 2 MG TABLET | $2.6218 per EA | +8.68% |
TIAGABINE HCL 4 MG TABLET | $2.5246 per EA | +11.05% |
TIAGABINE HCL 4 MG TABLET | $2.5246 per EA | +11.05% |
TIAGABINE HCL 4 MG TABLET | $2.0025 per EA | — |
TIAGABINE HCL 2 MG TABLET | $1.9228 per EA | — |
Frequently Asked Questions
What is Tiagabine Hydrochloride used to treat?
Tiagabine Hydrochloride is used to treat bipolar disorder and partial epilepsies, per the National Library of Medicine's MED-RT classification.
When did Tiagabine Hydrochloride become available as a generic?
FDA approved the first generic Tiagabine Hydrochloride (ANDA) on Nov 4, 2011. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Tiagabine Hydrochloride products are on the market?
The Tiagabine Hydrochloride drug market contains 10 NDCs from 3 manufacturers — 10 generic and 0 brand products.
What is the price range for Tiagabine Hydrochloride?
NADAC reference prices for Tiagabine Hydrochloride range from $1.9228 to $6.6190 per EA — the most expensive product costs about 3.4× the cheapest.
Which manufacturers make Tiagabine Hydrochloride?
3 manufacturers list Tiagabine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (4), Novadoz Pharmaceuticals LLC (4), Sun Pharmaceutical Industries Inc. (2).
How has the price of Tiagabine Hydrochloride changed recently?
Over the past 7 days, 4 Tiagabine Hydrochloride NDCs rose and 2 fell, with a market-wide average change of +6.5%.